Rockwell Medical, Inc. (NASDAQ:RMTI) Sees Large Increase in Short Interest

Key Points

• Short interest in Rockwell Medical, Inc. increased by 72.2% in August, reaching a total of 175,100 shares shorted, indicating heightened bearish sentiment.
• Rockwell Medical received a positive shift in analyst ratings, with Wall Street Zen upgrading the stock from a "sell" to a "hold" rating, and a consensus rating now categorized as "Buy."
• The company's recent earnings report showed that it met earnings per share estimates but fell short on revenue expectations, reporting $16.07 million against a consensus of $16.33 million.

Rockwell Medical, Inc. (NASDAQ:RMTI - Get Free Report) was the target of a large growth in short interest in August. As of August 15th, there was short interest totaling 175,100 shares, a growth of 72.2% from the July 31st total of 101,700 shares. Based on an average trading volume of 470,000 shares, the short-interest ratio is presently 0.4 days. Approximately 0.6% of the shares of the company are short sold. Approximately 0.6% of the shares of the company are short sold. Based on an average trading volume of 470,000 shares, the short-interest ratio is presently 0.4 days.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised Rockwell Medical from a "sell" rating to a "hold" rating in a report on Saturday, June 14th. One research analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $4.00.

Institutional Trading of Rockwell Medical

Hedge funds and other institutional investors have recently bought and sold shares of the company. Raymond James Financial Inc. purchased a new stake in Rockwell Medical during the fourth quarter valued at about $28,000. Barclays PLC lifted its holdings in Rockwell Medical by 27.5% in the 4th quarter. Barclays PLC now owns 28,854 shares of the company's stock worth $59,000 after buying an additional 6,229 shares during the period. Dimensional Fund Advisors LP bought a new position in Rockwell Medical in the 4th quarter worth $146,000. Finally, Panagora Asset Management Inc. bought a new position in shares of Rockwell Medical in the 2nd quarter worth approximately $41,000. Institutional investors own 23.31% of the company's stock.

Rockwell Medical Price Performance

Shares of Rockwell Medical stock traded up $0.04 on Thursday, reaching $1.69. 1,523,157 shares of the stock were exchanged, compared to its average volume of 583,692. The firm's 50 day moving average is $1.19 and its 200-day moving average is $1.17. The firm has a market cap of $58.19 million, a PE ratio of -28.17 and a beta of 1.83. Rockwell Medical has a one year low of $0.78 and a one year high of $5.15. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.51 and a current ratio of 2.89.

Rockwell Medical (NASDAQ:RMTI - Get Free Report) last issued its quarterly earnings results on Thursday, August 14th. The company reported ($0.05) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.05). Rockwell Medical had a negative return on equity of 6.79% and a negative net margin of 2.38%.The firm had revenue of $16.07 million during the quarter, compared to the consensus estimate of $16.33 million. Rockwell Medical has set its FY 2025 guidance at EPS. As a group, analysts anticipate that Rockwell Medical will post 0.03 EPS for the current fiscal year.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.